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The experimental study on end-stage dilated cardiomyopathy by
autotransplanting mesenchymal stem cells in swine
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Objectives: Cellular cardiomyoplasty has been proposed as an alternative strategy for
augmenting the function of diseased myocardium. Many data have suggested that
mesenchymal stem cells (MSC) may contribute to the healing of dilated cardiomy-
opathy. We will investigate whether autotransplantation with MSC can treat end-stage
heart failure and its mechanism.
Methods: Heart failure was created in 15 swines by right ventricular pacing-induced
at the rate of 230 beats per minute for 4 weeks, and 190 beats per minute for another 4
weeks.Bone marrow aspirate was taken from the iliac crest of healthy swines. MSCs
were isolated and co-cultured with 5-aza for 24hours. All the swines were divided into
three groups: DMEM implantation group (DMEM); MSC implantation group (MSC);
cardiomyocyte-like cell implantation group (CSC); The stem cells were injected into
coronary artery of the porcines with heart failure under DSA. The ejection fraction
(EF), the thickness of left ventricular wall, the diastolic diameter of left ventricle
(LVDd) and CO were assessed by echocardiography before and 4 week after
implantation.The TNF, TGF were detected with ELISA in the serum;the percentage of
apotosis, the concentrtion of collagen and the ratio of collagen I/III were detected in
the heart tissues.
Results: A part of MSCs induced by 5-aza had morphological changes and 31 %
stained positively Troponin I. Compared with that of the control group, LVEDd of
implantation groups was smaller 4 weeks after stem cells implantation (P<0.05),
whereas EF was increased (P<0.05). The TNF, the concentrtion of collagen and the
percentage of apotosis decreased, whereas TGF, the ratio of collagen I/III increased in
implantation groups vs control group.
Conclusions: The MSCs can differentiate into cardiomyocytes by 5-aza in
vitro.Autologous MSC transplantation improves contractibility of heart failure. This
improvement might result from BMC-associated myocardial regeneration and neo-
vascularization.This technique may lead to a promising therapy to treat congestive
heart failure.
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Objectives: The metallic stents have changed the way we treat coronary artery disease
dramatically. However, there are still many concerns. Stents made of biodegradable
materials appear to be the ideal alternatives. The aim of this study was to evaluate the
radial strength, biocompatibility, neointimal hyperplasia formation and vessel
remodeling of the novel biodegradable drug-eluting stent.
Methods: Six PowerStent Absorb stents and four TAXUS metallic drug-eluting
stents were implanted in ﬁve pigs. Each stent was delivered randomly to the vessel
segment in left anterior descending artery or right coronary artery of each pig.
Angiography and intravascular ultrasound were performed at the time immediately
after implantation and at 6 months. Specimens were harvested for histopathological
evaluation.
Results: Angiography showed all PowerStent Absorb stents remained structurally
stable after 6 months which were similar to the TAXUS stents. The mean luminal
diameter and mean lumen cross-sectional area of PowerStent Absorb stented arteries
at 6 months were no less than at the time immediately after implantation under IVUS.
Histopathological analyses showed evidence of signiﬁcantly greater restenosis in the
TAXUS group relative to the PowerStent Absorb group and a higher inﬂammatory
score. There is no signiﬁcant difference in stent recoil between PowerStent Absorb
group and TAXUS group. Complete reendothelialization was shown in the Power-
Stent Absorb group at 6 months.
Conclusions: The PowerStent Absorb stents exhibited acceptable recoiling,
controllable restenosis and reduced inﬂammation, thereby demonstrating improved
structural and functional performance of radial strength and biocompatibility, as well
as evidence of positive vascular remodeling in the porcine model.
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Research on pharmacological mechanisms of Qishen Granule on
transcriptome RNA-seq in mini pigs with cardiac functional insufﬁciency
and qi-deﬁciency and blood stasis syndrome (QDBS) induced by Ameroid
constricting ring
Chuo Wenjing1, Guo Shuzhen1, Qiu Qi2, Wang Yong1, Li Chun2, Lin Yang1,
Lian Hongjian1, Feng Xuanchao1, Fu Bangze1, Wang Wei1
1Beijing University of Chinese Medicine, 2Beijing Anzhen HospitalC72 JACC Vol 64/16/Suppl C j OctobObjectives: To explore the pharmacological mechanisms of Qishen Granule, a
compound Chinese herbal medicine, on RNA-seq in a mini pig model of cardiac
functional insufﬁciency and qi-deﬁciency and blood stasis syndrome (QDBS) induced
by Ameroid constricting ring. Moreover, drug targets and effect mechanisms path-
ways which may exist were also studied.
Methods: Establishment and assessment of a qi-deﬁciency and blood stasis syndrome
model with cardiac functional insufﬁciency experimental mini pigs (205 kg) were
instrumented with a size-matched Ameroid constrictor on the anterior descending
branch under general anesthesia in sterile conditions. Sham group didn’t place the
Ameroid constrictor, the other were the same to the model group. And the experi-
mental mini pigs of animal models were randomly divided into model group and
Qishen granule group with 6 in each group, sham operation group with 6 at the end of
experiment. 3 weeks after the operations, the animals were assessed with echocardi-
ography and electrocardiogram test. The day after the 3 weeks assessment, the animals
in different groups received different treatments. The therapeutic drugs stirred well
respectively with their normal feed then delivered for 8 weeks. Ischemic border
myocardium was obtained from the animals with Qishen granule group, model group
and the sham operated animals after administration 8 weeks. Myocardium samples
were sequencing by RNA-Seq with Illumina HiSeq 2000. Effective sequences were
referred to the ensemble sequence database for comparison. And effect mechanisms
pathways were discovered by KEGG.
Results: Compared with sham group, differential expressed genes in model group 90
genes up-regulated and 4 genes down-regulated were detected in RNA-Seq; compared
with model group, differential expressed genes in treatment group 12 genes up-
regulated, 14 genes down-regulated were detected. The differential expressed genes in
three group together were 10, they are natriuretic peptide A, natriuretic peptide B, Ras-
related protein Rab-3B, nestin, 6-phosphofructokinase, immunoglobulin lambda-like
polypeptide 1, synaptotagmin-1, NADPH2, large subunit ribosomal protein L22e,
alpha-2-antiplasmin, unknown gene. Compared with sham group, the differential
expressed genes in model group focused on p53 signaling pathway, leukocyte
transendothelial migration, primary immunodeﬁciency, cell adhesion molecules, but
compared with model group, the differential expressed genes mainly focused on fatty
acid biosynthesis, complement and coagulation cascade, renin-angiotensin system in
the treatment group.
Conclusions: RNA-Seq transcriptome results suggested Qishen Granule treatment of
cardiac functional insufﬁciency and qi-deﬁciency and blood stasis syndrome (QDBS)
mini pigs main pharmacological pathways were fatty acid biosynthesis and biological,
complement and coagulation cascade, renin-angiotensin system, oxidative stress and
some energy metabolism pathway.
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Objectives: Growing evidence has suggested that hypertension is associated with an
increased risk of cardiovascular and cerebrovascular diseases in general populations.
Apelin and its receptor APJ are widely distributed in the brain, heart, and vasculature,
and are emerging as an important regulator of body ﬂuid homeostasis, vasodilatation,
angiogenesis, and cardiovascular functions. We hypothesized that Apelin would exert
regulatory roles in hippocampal inﬂammation and oxidative stress in angiotensin II
(Ang II) -induced hypertensive mice.
Methods: 3-month-old C57BL/6J mice were randomized to either Ang II
(1.5 mg.kg-1.d-1) or saline (control) infusion with an osmotic minipump (model 1002)
for 2 weeks. The Ang II-infused mice were then treated with Apelin (200 mg.kg-1.d-1)
or AT1 receptor blocker irbesartan (50 mg.kg-1.d-1) for 2 weeks. Systolic blood
pressure (SBP) levels of mouse were measured non-invasively using the tail-cuff
method. We examined changes in hippocampal inﬂammation, oxidative stress, and
pathological signaling assessed by real-time PCR, Western blotting, thiobarbituric
acid analysis, and immunohistochemical staining, respectively.
Results: Compared with the normal control mice, Ang II infusion resulted in
marked increases in SBP levels, hippocampal expression of monocyte chemo-
attractant protein-1 (MCP-1) and tumor necrosis factor-a (TNF-a) and the contents
of malondialdehyde (MDA) in hypertensive mice (n¼5-6; P<0.01, respectively).
Intriguingly, downregulation of expression of brain-derived neurotrophic factor
(BDNF) and phosphorylated level of endothelial nitric oxide (NO) synthase (eNOS)
was observed in the hippocampus of the Ang II-mediated hypertensive mice, in
association with activation of STAT3 phosphorylated level and a marked reduction
of NO level (n¼5-6; P<0.05 or P<0.01, respectively). Notably, treatment with
both Apelin and irbesartan signiﬁcantly reduced SBP levels and prevented Ang
II-mediated increases in hippocampal inﬂammation and MDA contents in hyper-
tensive mice in response to Ang II (n¼5; P<0.05 or P<0.01, respectively). These
changes were associated with enhanced activation of the BDNF/eNOS/NO signaling
in the hippocampus of hypertensive mice, without having a differential effect on the
STAT3 level.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
Conclusions: Apelin treatment prevents Ang II-mediated hippocampal inﬂammation
and oxidant injury in the hypertensive mice through activation of the BDNF/eNOS/
NO signaling pathway, implicating beneﬁcial effects of the Apelin-APJ system on
the brain of hypertensive mice. Apelin may represent a potential candidate to treat
cardiovascular and cerebrovascular diseases.
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Enhanced inhibitory effects of amiodarone on hERG channels due to a mutation
A561V linked to long QT syndrome type 2
Li Guoliang, Sun Chaofeng
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Objectives: This study was to determine the potential of A561V on the response of
hERG channels to amiodarone and the mechanisms underlying the amiodarone-
induced long QT syndrome.
Methods: A561V-hERG plasmids were transfected into the HEK293 cells stably
expressing WT-hERG channels to mimic heterozygous mutant (WT+A561V-hERG).
Whole-cell patch clamp was used to evaluate electrophysiological consequences.
Laser confocal scanning microscopy was used to evaluate the membrane distribution
of hERG channel protein using a green ﬂuorescent protein tagged to the N-terminus
of hERG.
Results: In comparison of WT-hERG channels exposed to amiodarone, heterozygous
A561V-hERG channels showed signiﬁcant decrease in the maximal density of tail
currents in the presence of amidarone. The maximal density of tail currents was
52.76.65 pA/pF and 29.53.29 pA/pF for WT-hERG, 15.792.58 pA/pF and
9.271.43 pA/pF for heterozygous A561V-hERG, under control condition and
exposed to amiodarone, respectively Additionally, A561V-hERG also altered the
potential of amiodarone on the gating properties of hERG channels, including
activation, steady-state inactivation, recovery from inactivation and deactivation.
Images of amiodarone-treated cells expressing heterozygousA561V-hERG showed a
severe retention of protein in the endoplasmic reticulum and signiﬁcant reduction of
protein expression on the membrane in HEK293 cells, compared to the counterparts of
WT-hERG.
Conclusions: Amiodarone exerts a powerful inhibitory effect on the heterozygous
A561V-hERG channels, suggesting the additive suppression of WT-hERG currents by
A561V-hERG and amiodarone. This may explain the increased risk of drug-induced
LQTS and its propensity to severe arrhythmias in congenital LQT2 individuals
receiving amiodarone.
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Rosiglitazone decreases acute hyperglycemia through restoration of hepatic
insulin signaling in rat following myocardial infarction
Wang Jiali, Chen Yuguo
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Objectives: Stress hyperglycemia is a common pathological feature during the early
phase after acute myocardial infarction (AMI). Despite this, it is not clear whether the
insulin signaling cascades are perturbed after AMI. It is also unknown whether the
impairment of insulin signaling is etiological for hyperglycemia.
In this study, we evaluate 1) the alteration of insulin signaling cascades in major
insulin responsive tissues in a rat AMI model, 2) the role of insulin sensitizer
rosiglitazone (Ros) in potentiating insulin signaling and reducing hyperglycemia
after AMI.
Methods: The left anterior descending coronary artery of male rats was ligated in the
MI group. Rosiglitazone (4mg/kg) was administrated in rats 5min before ligation in
the MI+Ros group. After 30 minutes of ligation, rats were injected with insulin or PBS
intraperitoneally and sacriﬁced 5 minutes later. Plasma glucose and insulin levels were
measured. Expression and/or phosphorylation of insulin receptor b subunit (IRb),
insulin receptor substrate1 (IRS1), IRS2, IRSs-associated p85 subunit of PI3K and
Akt in liver, skeletal muscle and heart tissues were determined.
Results: Successful MI was conﬁrmed by increased CK-MB release and enlarged
myocardial infract aera by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The
plasma glucose levels in MI rats was signiﬁcantly elevated at 5min of ligation
(P<0.01) and increased gradually with the concentration reached 3.4 times than that of
sham controls at 30min. Similarly, rapid increase of insulin concentration in MI
groups was observed. Ros administration signiﬁcantly decreased glucose and insulin
levels in AMI rats.
Although the expression of IRb and IRS1 was comparable in liver tissue in MI and
control rats, insulin-stimulated tyrosine phosphorylation of IR and IRS1 were
signiﬁcantly reduced in MI rats. Similarly, the downstream key molecules such as the
attachment of PI3K p85 subunit to IRS1 was signiﬁcantly impaired, together with the
phosphorylation of Akt on ser473 in MI rats compared with control rats. By contrast,
the expression and phospharylation levels of IRS2, and IRS2-associated p85 in liver
were not signiﬁcantly different among all groups of rats. Ros treatment markedly
improved insulin-stimulated phosphorylation of IRb, IRS1 and Akt in liver tissue
of MI rats.
No signiﬁcant differences were observed for the phosphorylation levels of IRb,
IRS1 and Akt in skeletal muscle or heart among MI and control rats.
Conclusions: Insulin signaling cascades were impaired in liver of rats after AMI. Ros
could potentiate insulin signaling in liver tissue and alleviate systemic metabolicJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bdisorders, suggesting impairment of insulin signaling promote hyperglycemia in the
setting of AMI.
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The Myocardial Protection Effects of STV-1Na on Rats with Myocardial
Infarction
Luo Yanting, Liu Jinlai
Department of Cardiology, The Third Afﬁliated Hospital, Sun Yat-sen University
Objectives: To observe the myocardial protection effects of STV-1Na (a kaurane of
natural origin) on Sprague-Dawley (SD) rats with myocardial infarctions (MI).
Methods: SD rats were randomly assigned to Myocardial infarction group (MI)
(n¼30), sham group (S) (n¼30), MI-Trimetazidine group (MT) (0.03mg/100g,
n¼30), MI-low dose (ML) (0.05mg/100g, n¼30), MI-middle dose (MM) (0.1mg/
100g, n¼30) and MI-high dose (MH) STV-1Na group (0.4mg/100g, n¼30). The MI
model was set up in SD rats by permanent ligation of the left anterior descending
coronary artery (LAD).Sham group suture were through the LAD without ligation.
Before and after MI, in MI group and MI-T group normal saline and Trimetazidine
were given by gavage, and different dose groups of STV-1Na were given by gavage.
The changes of serum cTnI were observed at 8th, 24th, 48th hour after MI. In 1 week,
2 weeks, and 4 weeks after treatment, the area of myocardial infarction were analyzed,
maximal rate of left ventricular pressure (dp/dtmax) and minimum rate of left
ventricular pressure rise (dp/dtmin) were measured to evaluate the effects of STV-1Na.
The statistical signiﬁcance of differences was analyzed using SPSS 13.0 for Windows.
Groups were compared with one-way analysis of variance (ANOVA) test. A value of
P< 0.05 was considered statistically signiﬁcant.
Results: At 8th hour after MI the serum cTnI level of each group was no statistically
signiﬁcant difference (P>0.05). But ML, MM, MH and MT group decreased the
serum cTnI level signiﬁcantly at 24th hour after MI (P<0.01) (MI (42.35.4 ng/ml),
ML (17.04.3 ng/ml), MM (21.33.7 ng/ml), MH (22.26.5 ng/ml), MT
(22.75.3 ng/ml) ). ML group and MM group decreased the serum cTnI level
(P<0.05), and MH group decreased signiﬁcantly the serum cTnI level (P<0.01) at
48th hour after MI (MI (3.70.9 ng/ml), ML (1.30.7 ng/ml), MM (1.30.8 ng/ml),
MH (1.00.4 ng/ml) ). ML group and MM group decreased the myocardial infarction
area (P<0.05), MH group and MT group decreased the myocardial infarction area
signiﬁcantly (P<0.01) (MI (0.3620.027), ML (0.2840.027), MM (0.2680.023),
MH (0.2540.011), MT (0.2480.021) ). In 1 week after MI, MM group, MH group
and MT group increased dp/dtmax (P<0.05). The dp/dtmax were no signiﬁcant
difference (P>0.05) between ML group and MI group. (MI (6702329), ML
(7276221), MM (7782195), MH (7729172), MT (7535265) ). The dp/dtmin in
MT group and ML, MM, MH group were no statistically signiﬁcant difference
(P>0.05) (MI (-5400339), ML (-5690449), MM (-5564204), MH (-5646316),
MT (-5511400) ). In 2 weeks after MI, MT group (8101313) and ML, MM, MH
group increased the dp/dt max signiﬁcantly (P<0.01). (MI (5868412), MT
(8101313), ML (7658392), MM (8499343), MH (7521385) ) ; MT group, ML
group and MM group decreased the dp/dtmin (P<0.05). The dp/dtmin were no dif-
ference between MH group and MI group (P>0.05) (MI (-4750463), MT
(-6514493), ML (-6275623), MM (-7305491), MH (-5676640) ). In 4 weeks
after MI, MT group, ML group, MM group and MH group increased the dp/dt max
signiﬁcantly. (MI (5876200), MT (7629374, P<0.01), ML (7264348, P<0.05),
MM (7743242, P<0.01), MH (7537185, P<0.01) ).MT group, MM group and
MH group decreased the dp/dtmin signiﬁcantly (P<0.05); ML group didn’t no
decreased the dp/dtmin signiﬁcantly (P>0.05) (MI (-4546279), ML (-5528505),
MT (-5883436), MM (-6132533), MH (-5801343) ).
Conclusions: STV-1Na has myocardial protection effects on myocardial infarction
and improves myocardial systolic and diastolic function in SD rats with acute
myocardial infarction. The effects of STV-1Na were as good as the effects of
Trimetazidine.
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Effect of Myocardial Ischemic Postconditioning Protects Reperfusion Injury in
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Objectives: Clinical studies in patients with acute myocardial infarction have
demonstrated that Postconditioning (IPO) was effective in reducing infarct size. We
studied cardioprotection of IPO in diabetic heart existence or no, and how to wake-up
and recovery cardioprotection of IPO in diabetic heart, whether the diabetic heart is
amenable to ischaemic postconditioning is an important unanswered question.
Previous studies have demonstrated that postconditioning signals through the PI3K-
Akt kinase pathway. Other studies have documented impaired PI3K-Akt signalling in
the diabetic myocardium. We hypothesised that due to impaired signaling through the
PI3K-Akt pathway, postconditioning does not protect the diabetic heart.
Methods: Diabetic cardiomyopathy rats was induced by intraperitoneal streptozotocin
(STZ, 30mg/kg) injection.One week following STZ injection, and blood glucose
levels>120 mg/dL were included in the study. high-fat diet rats receiving high-
saturated-fat diet consisting of 35% fat, 35% carbohydrates, and 22% protein for 4
weeks.Hearts were rapidly excised and immediately mounted on Langendorff-perfu-
sion apparatus. Perfusion was maintained at a constant pressure of 75 mmHg.Isolated
hearts were obtained from two groups: healthy controls (n¼10), streptozotocin
(STZ) +HFD-induced diabetes (n¼12). All hearts underwent 25 min ischemia andasic and Translational Medicine C73
